GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shijiazhuang Yiling Pharmaceutical Co Ltd (SZSE:002603) » Definitions » Cyclically Adjusted Price-to-FCF

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Cyclically Adjusted Price-to-FCF : 148.25 (As of Jun. 07, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shijiazhuang Yiling Pharmaceutical Co Cyclically Adjusted Price-to-FCF?

As of today (2024-06-07), Shijiazhuang Yiling Pharmaceutical Co's current share price is ¥17.79. Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥0.12. Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted Price-to-FCF for today is 148.25.

The historical rank and industry rank for Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SZSE:002603' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 151.33   Med: 203.73   Max: 362.22
Current: 157.63

During the past years, Shijiazhuang Yiling Pharmaceutical Co's highest Cyclically Adjusted Price-to-FCF was 362.22. The lowest was 151.33. And the median was 203.73.

SZSE:002603's Cyclically Adjusted Price-to-FCF is ranked worse than
90.06% of 322 companies
in the Drug Manufacturers industry
Industry Median: 32.255 vs SZSE:002603: 157.63

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Shijiazhuang Yiling Pharmaceutical Co's adjusted free cash flow per share data for the three months ended in Mar. 2024 was ¥0.032. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ¥0.12 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shijiazhuang Yiling Pharmaceutical Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shijiazhuang Yiling Pharmaceutical Co Cyclically Adjusted Price-to-FCF Chart

Shijiazhuang Yiling Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 331.22 214.14

Shijiazhuang Yiling Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 281.21 203.93 223.09 214.14 175.08

Competitive Comparison of Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



Shijiazhuang Yiling Pharmaceutical Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=17.79/0.12
=148.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Shijiazhuang Yiling Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.032/115.2271*115.2271
=0.032

Current CPI (Mar. 2024) = 115.2271.

Shijiazhuang Yiling Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.020 98.200 0.023
201409 -0.455 98.900 -0.530
201412 0.030 99.000 0.035
201503 -0.109 99.900 -0.126
201506 -0.045 99.500 -0.052
201509 -0.170 100.500 -0.195
201512 0.098 100.600 0.112
201603 -0.034 102.200 -0.038
201606 0.069 101.400 0.078
201609 -0.056 102.400 -0.063
201612 0.188 102.600 0.211
201703 -0.093 103.200 -0.104
201706 -0.043 103.100 -0.048
201709 -0.046 104.100 -0.051
201712 0.149 104.500 0.164
201803 -0.111 105.300 -0.121
201806 0.192 104.900 0.211
201809 -0.026 106.600 -0.028
201812 -0.113 106.500 -0.122
201903 0.173 107.700 0.185
201906 -0.020 107.700 -0.021
201909 -0.153 109.800 -0.161
201912 -0.236 111.200 -0.245
202003 0.728 112.300 0.747
202006 0.071 110.400 0.074
202009 -0.352 111.700 -0.363
202012 -0.230 111.500 -0.238
202103 -0.144 112.662 -0.147
202106 -0.288 111.769 -0.297
202109 0.318 112.215 0.327
202112 0.028 113.108 0.029
202203 0.287 114.335 0.289
202206 0.495 114.558 0.498
202209 -0.155 115.339 -0.155
202212 1.332 115.116 1.333
202303 0.176 115.116 0.176
202306 0.158 114.558 0.159
202309 -0.372 115.339 -0.372
202312 -0.055 114.781 -0.055
202403 0.032 115.227 0.032

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shijiazhuang Yiling Pharmaceutical Co  (SZSE:002603) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Shijiazhuang Yiling Pharmaceutical Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Business Description

Traded in Other Exchanges
N/A
Address
No. 7 Tianfu street, Biology and medicine industrial base, Huangcun town, Daxing district, Beijing, CHN
Shijiazhuang Yiling Pharmaceutical Co Ltd is a China-based company engages in the pharmaceutical manufacturing. The company is principally engaged in the research, development, manufacturing, and sales of traditional Chinese pharmaceutical products, especially in the fields of cardiovascular and cerebrovascular diseases, respiratory diseases, tumor, diabetes and related complications. Its products include innovative drug series, chemical drugs, Chinese medicine series, and health products.
Executives
Zhang Qiu Lian Directors, executives
Han Yue Zhi Executives
Zhao Shao Hua Executives
Wang Wei Executives
Gao Xue Dong Supervisors
Wu Yi Ling Director
Gao Xiu Qiang Executives
Wu Xiang Jun Directors, executives
Guo Shuang Geng Director
Wang Hua Securities Affairs Representative
Dai Feng Xiang Directors, executives
Liu Gen Wu Supervisors
Wang Wei Ping Directors, executives
Xu Wei Dong Director
Wu Rui Directors, executives

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Headlines

No Headlines